Clinical Course Of Disease In Participants With FA-CM

NCT06865482 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2026-04-15

No results posted yet for this study

Summary

Characteristics and clinical course of disease In participants with cardiomyopathy associated with Friedreich Ataxia (CLARITY-FA)

Conditions

Sponsors & Collaborators

  • Lexeo Therapeutics

    lead INDUSTRY

Principal Investigators

  • Lexeo Clinical Trials · Lexeo Therapeutics

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2027-09-30
Completion
2027-09-30

Countries

  • United States
  • Brazil
  • Canada
  • Czechia
  • France
  • Germany
  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06865482 on ClinicalTrials.gov